3 AI Chip Stocks to Buy as the Sell-Off Continues

AI chip stocks cooled amid fears that cloud/AI infrastructure spending could slow, but hyperscalers are signaling higher spend next year. Bank of America projects worldwide cloud and AI data-center capex to rise 40%-50% YoY to ~$1.5T in 2027, supporting the bull case for Nvidia, AMD, and Broadcom. Nvidia is valued at ~15x fiscal 2028 (Jan 2028) estimated earnings on reported ~85% last-quarter revenue growth; AMD is positioned for inference and agentic-AI-driven CPU demand; and Broadcom trades at ~19x fiscal 2027 (Nov 2027) estimates despite custom-chip growth expected to top $100B next year. Overall, the article frames the pullback as a buying opportunity rather than a demand break.

Analysis

This is more a positioning reset than a fresh fundamental revelation. The cleanest read-through is that AI spend is broadening from training GPUs into inference, networking, and CPU-heavy agentic workloads, which should increase silicon content per rack but also diversify who captures the dollar pool. That is incrementally positive for AVGO and AMD on a 6-18 month view, while NVDA remains the highest-quality compounder because its stack capture can defend share even if unit growth normalizes.

The near-term market risk is that these names are already the crowded expression of "AI capex stays high," so any in-line hyperscaler commentary may still fail to re-rate them. Over the next 1-3 months, the key catalyst is not capex headlines but evidence of backlog conversion, order timing, and whether custom silicon is a net share gain for the ecosystem or just a substitution inside the same wallet. If 2026 cloud capex guides down, or if GPU gross margins soften faster than expected, the bull case de-risks quickly.

Contrarianly, the consensus may be underestimating how much of the value chain shifts away from the obvious leaders as inference scales: networking, memory bandwidth, and custom ASIC integration should gain bargaining power versus generic accelerators. That makes AVGO the cleaner relative-value long versus NVDA if you want less multiple risk and more mix-tailwind. AMD is the highest-beta expression, but it is also the most execution-sensitive if agentic AI adoption lags the narrative.

Key Decisions for Investors

• Long AVGO / short NVDA for 1-3 months as a relative-value pair: thesis is valuation support plus better mix exposure to custom silicon and networking; cover if NVDA re-accelerates on Blackwell shipment data or AVGO's AI backlog conversion disappoints.
• Add to NVDA only on pullbacks and hold for 12-18 months: this is a quality compounder, but the next leg needs proof that full-stack monetization is expanding, not just capex headlines. Falsifier: any downward revision to 2026 hyperscaler capex or a gross-margin guide rollover.
• Overweight AMD on a 6-12 month horizon for higher torque to inference/agentic AI, but size smaller than NVDA/AVGO because execution risk is higher. Watch shipment ramps and design-win conversion; a delay of even one quarter would likely underperform the AI complex.
• If you want sector beta without single-name earnings risk, accumulate SMH on weakness rather than chasing individual names after the selloff. This is the cleaner expression if capex visibility is still noisy and the next catalyst is earnings season.